Your browser doesn't support javascript.
loading
Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: Phenotypes, endotypes, and management with desensitization.
Jimenez-Rodriguez, Teodorikez-Wilfox; de Las Vecillas, Leticia; Labella, Marina; Lynch, Donna-Marie; Besz, Kylie Marie; Marquis, Kathleen; Burgos, Amparo; Soriano Gomis, Victor; Lozano, Inmaculada; Antón, Rosa Ana Montoyo; de la Calle, Francisco Marco; González Delgado, María Purificación; Gutiérrez, Aurora; Montenegro, Estefanía; Rodríguez, Fernando; Fernández Sánchez, Francisco Javier; Castells, Mariana.
  • Jimenez-Rodriguez TW; Allergy Section, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.
  • de Las Vecillas L; ARADyAL Spanish Network (RD16/0006), Instituto de Salud Carlos III (ISCIII), Fundación Española para la Ciencia y la Tecnología (FECyT), Madrid, Spain.
  • Labella M; Allergy Section, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain.
  • Lynch DM; Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain.
  • Besz KM; ARADyAL Spanish Network (RD16/0006), Instituto de Salud Carlos III (ISCIII), Fundación Española para la Ciencia y la Tecnología (FECyT), Madrid, Spain.
  • Marquis K; Allergy Clinical Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.
  • Burgos A; Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.
  • Soriano Gomis V; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Lozano I; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Antón RAM; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • de la Calle FM; Pharmacy Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.
  • González Delgado MP; Allergy Section, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.
  • Gutiérrez A; ARADyAL Spanish Network (RD16/0006), Instituto de Salud Carlos III (ISCIII), Fundación Española para la Ciencia y la Tecnología (FECyT), Madrid, Spain.
  • Montenegro E; Department of Clinical Medicine, Miguel Hernández University, Alicante, Spain.
  • Rodríguez F; Oncology Section, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.
  • Fernández Sánchez FJ; Oncology Day Hospital Nursing Service, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.
  • Castells M; Immunology Section, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.
Allergy ; 79(3): 679-689, 2024 Mar.
Article en En | MEDLINE | ID: mdl-37916741
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hipersensibilidad a las Drogas / Hipersensibilidad / Antineoplásicos Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hipersensibilidad a las Drogas / Hipersensibilidad / Antineoplásicos Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article